Urology News and Research

Latest Urology News and Research

Allergan third quarter diluted loss per share increases to $2.21

Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.

1 Nov 2010

Endo third quarter total revenues increase 23% to $444.1 million

Endo Pharmaceuticals today reported financial results for the third quarter 2010.

1 Nov 2010

Saving soldier's life takes precedence over treating traumatic urologic injury on battlefield

Saving a soldier's life takes precedence over treating traumatic urologic injuries on the battlefield, a Medical College of Georgia researcher says.

30 Oct 2010

Physicians suggest patients who receive MoM hip replacement to pay attention on post-operative pain

Total hip arthroplasty (THA) is one of the most successful surgeries of the past several decades. This procedure has relieved pain and restored movement to hundreds of thousands of people. The decision to have hip replacement surgery should be only made after discussion between the patient and his or her orthopaedic surgeon.

30 Oct 2010

Karmanos, WSU SOM present long-term results of fast neutron radiotherapy in localized prostate cancer

Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit will present the world's largest study that shows the long-term results of fast neutron radiotherapy (FNRT) in the treatment of localized prostate cancer. The findings will be formally announced Tuesday, Nov. 2, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting

30 Oct 2010

Coloplast announces acquisition of Mpathy Medical

Coloplast announced today that it has acquired Mpathy Medical, a fast growing company in women's health, for a total cash consideration of USD 30m equal to DKK162m, potentially increasing to a total of USD 35m equal to DKK 189m on a cash and debt free basis. The acquisition expands the Coloplast female health portfolio of innovative product technologies and surgical solutions for female stress urinary incontinence and pelvic organ prolapse.

29 Oct 2010

NeoGenomics third quarter revenue grows 19% to $8.7 million

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the third quarter 2010.

28 Oct 2010

NICE issues PTNS guidance for overactive bladder

Uroplasty, Inc. announced today that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) issued a guidance document titled "Percutaneous Posterior Tibial Nerve Stimulation for Overactive Bladder Syndrome," reinforcing the safety and effectiveness of PTNS for overactive bladder.

28 Oct 2010

Annals of Urology to publish NAFC research on overactive bladder symptoms

Research by the National Association For Continence (NAFC) about the frustration endured by middle-aged women, who have overactive bladder (OAB) symptoms, will be published in the inaugural issue of Annals of Urology from San Lucas Medical.

28 Oct 2010

JMC Professor wins Karl Storz Lifetime Achievement Award in Endourology

Demetrius H. Bagley, M.D., the Nathan Lewis Hatfield Professor of Urology in the Department of Urology at Jefferson Medical College (JMC) of Thomas Jefferson University was recently honored as the 2010 recipient of the Karl Storz Lifetime Achievement Award in Endourology at the World Congress of Endourology. He is also a full Professor of Radiology.

28 Oct 2010

New GlideScope Direct intubation trainer to facilitate instruction for classic direct laryngoscopy

Verathon Inc. is pleased to introduce the GlideScope Direct intubation trainer, designed to facilitate instruction of classic direct laryngoscopy.

28 Oct 2010

Nymox updates NX-1207 Phase 3 pivotal trials for benign prostatic hyperplasia

Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 pivotal trials for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH).

28 Oct 2010

Scientists discover MSMB protein in urine can predict prostate cancer risk

British scientists have identified a protein in urine that can help indicate which patients are at an increased risk of developing prostate cancer. The Cancer Research UK Cambridge Research Institute and The Institute of Cancer Research found that the level of MSMB protein in urine could provide a fast and accurate prostate cancer diagnosis for doctors and patients, potentially replacing the currently painful and more costly approach a blood sample.

27 Oct 2010

New type of radiation reduces GI side effects but does not improve survival rate in prostate cancer patients

A new British review of existing research suggests that while a newer type of radiation for the treatment of prostate cancer does not help patients live longer compared to an older type at least when similar doses are given it does appear to reduce gastrointestinal side effects.

27 Oct 2010

ENDOMETRIN Vaginal Insert offers effective luteal support in IVF procedures

Ferring Pharmaceuticals Inc. presented study results demonstrating that ENDOMETRIN (progesterone) Vaginal Insert provides effective luteal support compared to intramuscular (IM) progesterone-in-oil (PIO) in patients undergoing in vitro fertilization (IVF) using gonadotropin releasing hormone (GnRH) antagonist.

27 Oct 2010

IMRT reduces gastrointestinal complications in prostate cancer patients

Prostate cancer patients who receive intensity modulated radiation therapy (IMRT) are less apt to suffer serious gastrointestinal complications following their treatment than those who receive three-dimensional conformal radiotherapy (CRT), according to new research from the University of Pennsylvania School of Medicine.

27 Oct 2010

Caldera Medical relocates to new, larger facility

Caldera Medical today announced its relocation to a new facility in Agoura Hills, CA. The former corporate headquarters of DTS offers Caldera approximately eight times more square footage in anticipation of continued growth as well as capability expansion.

26 Oct 2010

First step in development of artificial human testicle

After more than 30 years of unsuccessful efforts by numerous investigators, researchers have now found a way to propagate primary human Sertoli cells in the laboratory. Derived from the testis, it has been difficult to maintain Sertoli cells, the "nurse" cells responsible for overseeing sperm production, outside of the human body.

26 Oct 2010

Combination of radiation and hormone therapy improves survival rate among prostate cancer patients

Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).

26 Oct 2010

Chemoradiotherapy can reduce bladder cancer recurrence

A major bladder cancer trial, funded by Cancer Research UK, has shown that adding two commonly used chemotherapy drugs to traditional radiotherapy can reduce the chance of a patient's tumour coming back by a third.

26 Oct 2010

Urology News and Research

Latest Urology News and Research

Allergan third quarter diluted loss per share increases to $2.21

Endo third quarter total revenues increase 23% to $444.1 million

Saving soldier's life takes precedence over treating traumatic urologic injury on battlefield

Physicians suggest patients who receive MoM hip replacement to pay attention on post-operative pain

Karmanos, WSU SOM present long-term results of fast neutron radiotherapy in localized prostate cancer

Coloplast announces acquisition of Mpathy Medical

NeoGenomics third quarter revenue grows 19% to $8.7 million

NICE issues PTNS guidance for overactive bladder

Annals of Urology to publish NAFC research on overactive bladder symptoms

JMC Professor wins Karl Storz Lifetime Achievement Award in Endourology

New GlideScope Direct intubation trainer to facilitate instruction for classic direct laryngoscopy

Nymox updates NX-1207 Phase 3 pivotal trials for benign prostatic hyperplasia

Scientists discover MSMB protein in urine can predict prostate cancer risk

New type of radiation reduces GI side effects but does not improve survival rate in prostate cancer patients

ENDOMETRIN Vaginal Insert offers effective luteal support in IVF procedures

IMRT reduces gastrointestinal complications in prostate cancer patients

Caldera Medical relocates to new, larger facility

First step in development of artificial human testicle

Combination of radiation and hormone therapy improves survival rate among prostate cancer patients

Chemoradiotherapy can reduce bladder cancer recurrence

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Urology News and Research

Latest Urology News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in